GEA GROUP
Explore by topic
5-year stock timeline
2026 (H1 — Aug 2026)
Continued strong operational execution with management restatement of 2026 guidance: organic revenue growth target 5–7% and EBITDA margin before restructuring 16.6–17.2%. Q2 and H1 statements showed double-digit order intake growth and rising profitability. The market narrative shifted toward profitable growth and execution credibility, treating GEA as a reliable industrial compounder with improving margins and visible backlog-driven revenue acceleration. Chart phase showed a rally from 2025 levels with higher highs and higher lows, continuing an uptrend. [1][2]
2026-05-11 (Q1 2026 results)
Q1 2026 reported EPS 0.64 EUR, a slight beat versus consensus. Record Q1 EBITDA margins and solid revenue matched expectations. The result reinforced the view that margin improvements were sustainable, though short-term investor reaction included profit-taking on valuation. Medium-term sentiment remained constructive as guidance proved strong. A short-term pullback occurred within a broader uptrend. [6][11][13]
2026-01-26 (Preliminary FY–2025 figures)
GEA published preliminary 2025 results showing order intake €5.9bn (organic +9.1%), revenue €5.5bn (organic +3.7%), and EBITDA before restructuring €907m (margin 16.5%), all above prior guidance and market expectations. The market repriced the company higher on evidence of accelerating order momentum and margin expansion. Confidence rose that prior cost and efficiency programs were bearing fruit. A breakout from the 2024–25 trading range into a sustained rally followed the results beat. [7][10]
2025 (Full year 2025 / FY–2025 Annual Report published March 2026)
Full-year reporting confirmed preliminary figures. Management upgraded medium-term targets and signalled continued margin focus and higher organic growth aspiration for 2026. Investor perception shifted from cyclical industrial toward higher-quality engineered-equipment compounder with improved capital allocation, higher EPS and dividend outlook, and reduced perceived execution risk. A strong uptrend persisted through 2025 with accelerated momentum in H2 2025 as previous resistance levels cleared. [5][12]
2025 Q2–Q3 (mid-2025 guidance upgrades)
During mid-2025 reporting, GEA upgraded full-year guidance with narrower and higher margin guidance and higher organic growth bands following better-than-expected order intake and margin improvements in Q2. The narrative of operational improvement was reinforced and restructuring and productivity measures were validated. Analysts revised models upward. A momentum phase sustained the rally and breakout following the guidance upgrades. [9][3]
2024 (FY–2024 results / transition year)
2024 delivered solid top line at approximately €5.4bn but margins remained below levels achieved in 2025. Order intake reached approximately €5.55bn as the company rebuilt organic growth after earlier weakness. The market viewed GEA as in transition: a recovery story from pandemic and supply-chain impacts, with management credibility being rebuilt through disciplined margin focus. The end of multi-quarter consolidation came with rangebound price action and signs of base formation ahead of the 2025 breakout. [1][12]
2022–2023 (post-pandemic recovery / margin actions)
The company executed cost and efficiency programs and focused on higher-margin equipment and services. Order patterns recovered but macro uncertainty surrounding energy and China slowdown weighed on visibility. Investors viewed GEA as mid-cycle industrial recovering from COVID disruptions with sentiment cautious but improving as execution on margin measures became visible. Gradual base formation occurred with intermittent rallies and pullbacks in choppy but slowly improving price action. [15][12]
2021 (early recovery / dividend and governance)
GEA returned to dividend increases and emphasized balance-sheet strength as operations recovered from pandemic disruption. Perception was cautious optimism with the company seen as a value or turnaround candidate with improving cash flow but still cyclical exposure. A drawdown from pandemic lows transitioned into early recovery and a long flat base. [15]
Key risks and downside factors
GEA Group supplies engineering and technology systems globally to food, beverage, dairy, pharmaceutical, and chemical processors. The company competes against large diversified engineering groups with overlapping portfolios, specialized niche players, and lower-cost Asian competitors in process equipment and integrated systems—heat transfer, separation, filling, packaging, and process skids among them. The business faces headwinds from cyclical capital spending patterns, competitive margin pressure, regulatory and food-safety compliance requirements, and volatility in supply-chain costs and raw-material pricing [8], [3].
- GEA's equipment demand follows the capital spending cycles of its food, beverage, and pharmaceutical customers, creating volatility in both order intake and revenue.
- Large diversified competitors and low-cost Asian manufacturers create persistent margin pressure through pricing compression on standardized equipment.
- Regulatory and product-safety risk stems from potential failures or noncompliance in hygienic and aseptic systems, which could trigger recalls, expose the company to liability, and damage reputation across food and pharmaceutical end markets.
- Supply-chain and input-cost risk: disruptions or spikes in steel, electronics, and component availability can drive up project costs and push back deliveries, which pressures both margins and the backlog.
Competitive landscape
GEA Group is a German engineering company that builds process technology and equipment for food, beverage, dairy, pharmaceutical and chemical industries. Its main competitors supply heat-transfer systems, separation equipment, filling and packaging machinery, and complete processing lines—names like Alfa Laval, Krones, SPX Flow, JBT, and IMA. The company also faces competition from larger industrial engineering groups and private packaging specialists. The business carries exposure to cyclical capital spending patterns, competitive pressure on margins, fluctuating component and commodity costs, supply chain and project execution risks, and the regulatory demands that come with serving food and pharmaceutical sectors.
| Company | Ticker |
|---|---|
| Krones AG | KRN.XETRA |
| JBT Corporation | JBT.NYSE |
| IMA S.p.A. | IMA.MI |
Private competitors
- Tetra Pak (part of Tetra Laval Group)
- Coesia S.p.A. (private Italian packaging/automation group)
- Various specialist private skid/system integrators and regional OEMs (China/India)
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialPerformance Figures of GEA GROUP
Relative Performance vs Benchmarks
| Period | GEA GROUP | vs DAX | vs S&P 500 (SPY) |
|---|---|---|---|
| 1M | +7.63% | +1.15% | +3.18% |
| 3M | +17.57% | +8.80% | +12.20% |
| 6M | +1.70% | -4.07% | -12.60% |
| 1Y | +3.20% | -5.34% | -18.79% |
| 3Y | +95.00% | +26.34% | +10.30% |
| 5Y | +91.01% | +24.95% | +3.94% |
Get More Stock Analyses Like This
Receive hand-picked stock recommendations with detailed analyses every week
Start Free TrialHistorical valuation trends
How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.
| Period | P/E Ratio | P/S Ratio | P/B Ratio | P/CF Ratio |
|---|---|---|---|---|
| Current | 24.3 | 1.9 | 4.2 | 14.6 |
| 1Y ago | 26.5 | 1.9 | 4.7 | 15.0 |
| 3Y ago | 14.6 | 1.2 | 2.8 | 15.3 |
| 5Y ago | 44.7 | 1.5 | 3.5 | 10.6 |
Frequently Asked Questions
Where is the GEA GROUP stock traded?
What does GEA GROUP do?
What are the key metrics for G1A.XETRA?
How has GEA GROUP's stock price performed?
How is G1A.XETRA valued?
Does G1A.XETRA pay dividends?
What are the key risks when investing in G1A.XETRA?
- GEA's equipment demand follows the capital spending cycles of its food, beverage, and pharmaceutical customers, creating volatility in both order intake and revenue.
- Large diversified competitors and low-cost Asian manufacturers create persistent margin pressure through pricing compression on standardized equipment.
- Regulatory and product-safety risk stems from potential failures or noncompliance in hygienic and aseptic systems, which could trigger recalls, expose the company to liability, and damage reputation across food and pharmaceutical end markets.
- Supply-chain and input-cost risk: disruptions or spikes in steel, electronics, and component availability can drive up project costs and push back deliveries, which pressures both margins and the backlog.
Who are the main competitors of GEA GROUP?
- Krones AG (KRN.XETRA)
- JBT Corporation (JBT.NYSE)
- IMA S.p.A. (IMA.MI)
When does GEA GROUP report earnings?
Key Metrics
Valuation Metrics
Profitability Metrics
Growth Metrics
Dividend history
Long-term record of paid dividends (amount per share and dividend yield at the time of payment).
| Year | Dividend | Yield at payment | Avg. yield |
|---|---|---|---|
| 2026 | 1.30 EUR | 2.20% | 2.17% |
| 2025 | 1.15 EUR | 2.01% | |
| 2024 | 1.00 EUR | 2.64% | |
| 2023 | 0.95 EUR | 2.20% | |
| 2022 | 0.90 EUR | 2.40% | |
| 2021 | 0.85 EUR | 2.33% | |
| 2020 | 0.43 EUR | 1.48% | |
| 2020 | 0.42 EUR | 2.00% | |
| 2019 | 0.85 EUR | 3.34% | |
| 2018 | 0.85 EUR | 2.46% | |
| 2017 | 0.80 EUR | 2.07% | |
| 2016 | 0.80 EUR | 1.90% | |
| 2015 | 0.70 EUR | 1.53% | |
| 2014 | 0.60 EUR | 1.86% | |
| 2013 | 0.55 EUR | 2.16% |
Earnings history & estimates
Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.
Historical earnings performance
Upcoming earnings report
Analyst estimates for upcoming periods
Key financial figures
Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | 5.50B | 5.42B | 5.37B | 5.16B | 4.70B |
| Operating income (EBIT) | 639.78M | 593.03M | 504.90M | 466.88M | 380.90M |
| Net income | 414.01M | 385.04M | 392.76M | 401.43M | 305.17M |
| Free cash flow | 472.94M | 473.01M | 305.21M | 265.53M | 552.15M |
| Total assets | 6.09B | 6.03B | 5.95B | 5.92B | 5.87B |
| Equity | 2.45B | 2.42B | 2.40B | 2.28B | 2.08B |
| Net debt | -378.94M | -326.14M | -367.19M | -329.97M | -499.66M |
PWP Leeway UG (haftungsbeschränkt)
